Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone

被引：0
作者：
Liew, Siew Fai [1 ]
Bhanu, Gupta [1 ]
Lee, Jimmy [1 ]
Chee, Kok Seng [1 ]
Neo, Li Qi [1 ]
Tang, Charmaine [1 ]
机构：
[1] Inst Mental Hlth, Singapore, Singapore
来源：
BJPSYCH OPEN | 2021年 / 7卷
关键词：
D O I：
10.1192/bjo.2021.663
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S247 / S248
页数：4
相关论文
共 50 条
  • [21] Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol
    Volavka, J
    Czobor, P
    Nolan, K
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, JP
    Cooper, TB
    Lieberman, JA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (02) : 225 - 228
  • [22] Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone
    Dernovsek, MZ
    Tavcar, R
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (04) : 237 - 238
  • [23] Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol
    Volavka, J
    Czobor, P
    Cooper, TB
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, JP
    Lieberman, JA
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (01) : 57 - 61
  • [24] Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders
    Migliardi, Gaetana
    D'Arrigo, Concetta
    Santoro, Vincenza
    Bruno, Antonio
    Cortese, Lara
    Campolo, Domenica
    Cacciola, Massimo
    Spina, Edoardo
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (02) : 107 - 113
  • [25] Efficacy of risperidone, olanzapine and clozapine in the treatment of therapy resistant schizophrenia
    Wardenier, M
    Slooff, CJ
    Arends, J
    ACTA NEUROPSYCHIATRICA, 2000, 12 (04) : 183 - 192
  • [26] Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents
    C. Fleischhaker
    P. Heiser
    K. Hennighausen
    B. Herpertz-Dahlmann
    K. Holtkamp
    C. Mehler-Wex
    R. Rauh
    H. Remschmidt
    E. Schulz
    A. Warnke
    Journal of Neural Transmission, 2007, 114 : 273 - 280
  • [27] Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
    Bilder, RM
    Goldman, RS
    Volavka, J
    Czobor, P
    Hoptman, M
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, J
    Kunz, M
    Chakos, M
    Cooper, TB
    Horowitz, TL
    Lieberman, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) : 1018 - 1028
  • [28] Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents
    Fleischhaker, C.
    Heiser, P.
    Hennighausen, K.
    Herpertz-Dahlmann, B.
    Holtkamp, K.
    Mehler-Wex, C.
    Rauh, R.
    Remschmidt, H.
    Schulz, E.
    Warnke, A.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (02) : 273 - 280
  • [29] A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder
    Guille, C
    Sachs, GS
    Ghaemi, SN
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (09) : 638 - 642
  • [30] Comparison of metabolic parameters among patients of schizophrenia on treatment with Olanzapine and Risperidone
    Singh, Archana
    Tomar, Abhay Singh
    Khess, C. R. J.
    Munda, Sanjay
    Siddiqui, Aleem
    Shivani
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S96 - S96
12345